1. Home
  2. ARWR vs YY Comparison

ARWR vs YY Comparison

Compare ARWR & YY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • YY
  • Stock Information
  • Founded
  • ARWR 2003
  • YY 2005
  • Country
  • ARWR United States
  • YY Singapore
  • Employees
  • ARWR N/A
  • YY N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • YY EDP Services
  • Sector
  • ARWR Health Care
  • YY Technology
  • Exchange
  • ARWR Nasdaq
  • YY Nasdaq
  • Market Cap
  • ARWR 2.6B
  • YY 2.2B
  • IPO Year
  • ARWR 1993
  • YY 2012
  • Fundamental
  • Price
  • ARWR $19.90
  • YY $48.97
  • Analyst Decision
  • ARWR Buy
  • YY Hold
  • Analyst Count
  • ARWR 11
  • YY 3
  • Target Price
  • ARWR $43.33
  • YY $35.00
  • AVG Volume (30 Days)
  • ARWR 2.5M
  • YY 336.1K
  • Earning Date
  • ARWR 02-10-2025
  • YY 03-17-2025
  • Dividend Yield
  • ARWR N/A
  • YY 1.63%
  • EPS Growth
  • ARWR N/A
  • YY N/A
  • EPS
  • ARWR N/A
  • YY 3.11
  • Revenue
  • ARWR $2,500,000.00
  • YY $2,258,181,000.00
  • Revenue This Year
  • ARWR $3,336.78
  • YY $0.76
  • Revenue Next Year
  • ARWR $124.29
  • YY $1.88
  • P/E Ratio
  • ARWR N/A
  • YY $16.05
  • Revenue Growth
  • ARWR N/A
  • YY N/A
  • 52 Week Low
  • ARWR $17.05
  • YY $27.88
  • 52 Week High
  • ARWR $36.72
  • YY $51.82
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 49.40
  • YY 62.93
  • Support Level
  • ARWR $17.57
  • YY $46.64
  • Resistance Level
  • ARWR $21.84
  • YY $51.19
  • Average True Range (ATR)
  • ARWR 1.06
  • YY 1.93
  • MACD
  • ARWR 0.11
  • YY 0.26
  • Stochastic Oscillator
  • ARWR 54.57
  • YY 71.21

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About YY JOYY Inc.

JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.

Share on Social Networks: